Literature DB >> 29666481

Expanding definitions of HER2 positivity.

Steven Sorscher1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29666481     DOI： 10.1038/modpathol.2017.141

Source DB:  PubMed          Journal:  Mod Pathol        ISSN： 0893-3952            Impact factor:   7.842


× No keyword cloud information.
  2 in total

1.  HER2 immunohistochemical and fluorescence in situ hybridization discordances in invasive breast carcinoma with micropapillary features.

Authors:  Rachel L Stewart; Justin E Caron; Evin H Gulbahce; Rachel E Factor; Katherine B Geiersbach; Erinn Downs-Kelly
Journal:  Mod Pathol       Date:  2017-07-28       Impact factor: 7.842

2.  Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.

Authors:  Antonio C Wolff; M Elizabeth H Hammond; David G Hicks; Mitch Dowsett; Lisa M McShane; Kimberly H Allison; Donald C Allred; John M S Bartlett; Michael Bilous; Patrick Fitzgibbons; Wedad Hanna; Robert B Jenkins; Pamela B Mangu; Soonmyung Paik; Edith A Perez; Michael F Press; Patricia A Spears; Gail H Vance; Giuseppe Viale; Daniel F Hayes
Journal:  J Clin Oncol       Date:  2013-10-07       Impact factor: 44.544
  2 in total
  1 in total

1.  HER2 Immunohistochemistry in Invasive Micropapillary Breast Carcinoma: Complete Assessment of an Incomplete Pattern.

Authors:  Marjorie Perron; Hannah Y Wen; Matthew G Hanna; Edi Brogi; Dara S Ross
Journal:  Arch Pathol Lab Med       Date:  2021-08-01       Impact factor: 5.686
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.